Detection of 1,N6-ethenoadenine in rat urine after chloroethylene oxide exposure

Carcinogenesis

Volumn 19, Issue 10, 1998, Pages 1763-1769

  Holt, S ^a   Yen, T Y ^a   Sangaiah, R ^a   Swenberg, J A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE DERIVATIVE; CHLOROETHYLENE OXIDE; DNA; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VINYL CHLORIDE; 1,N(6) ETHENOADENINE; 1,N(6)-ETHENOADENINE; ADENINE; DRUG DERIVATIVE; ETHYLENE OXIDE; MUTAGENIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOAFFINITY CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; URINE LEVEL; AFFINITY CHROMATOGRAPHY; ANIMAL; FISCHER 344 RAT; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; SPECTROFLUOROMETRY; URINE;

ADENINE; ANIMALS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHYLENE OXIDE; INJECTIONS, INTRAVENOUS; MALE; MASS SPECTROMETRY; MUTAGENS; RATS; RATS, INBRED F344; SPECTROMETRY, FLUORESCENCE;

EID: 0031595918     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.10.1763     Document Type: Article

References (36)

1. Harris,C.C. (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res., 51, 5023s-5044s.
2. 32P-postlabelling. Carcinogenesis, 16, 613-617.
3. 4-ethenocytosine in DNA bases. Proc. Am. Assoc. Cancer Res., 34, 136.
4. 4-etheno-2′-deoxycytidine in cellular DNA. Carcinogenesis, 15, 1647-1652.
5. Creech,J.L.Jr. and Johnson,M.N. (1974) Angiosarcoma of the liver in the manufacture of polyvinyl chloride. J. Occup. Med., 16, 150-151.
6. IARC (1988) Vinyl Chloride, Polyvinylchloride, and Vinyl Chloride-Vinyl Acetate Polymers, Vol. 19, 1979 pp. and Supplement 7. IARC Monographs, IARC, Lyon.
7. Guengerich,F.P., Kim,D.H. and Iwasaki,M. (1991) Role of human cytochrome P450 IIE1 in the oxidation of several low molecular weight cancer suspects. Chem. Res. Toxicol., 4, 168-179.
8. Guengerich,F.P., Mason,P.S., Stott,W.T., Fox,T.R. and Watanabe,P.G. (1981) Role of 2-haloethylene oxides and 2-haloacetaldehydes derived form vinyl bromide and vinyl chloride in irreversible binding to protein and DNA. Cancer Res., 41, 4391-4398.
9. Guengerich,F.P. (1992) Roles of the vinyl chloride oxidation products 2-chlorooxirane and 2-chloroacetaldehyde in the in vitro formation of etheno adducts of nucleic acid bases. Chem. Res. Toxicol., 5, 2-5.
10. Malaveille,C., Bartsch,H., Barbin,A., Camus,A.M., Momesano,R., Croisy,A. and Jacquignon,P. (1975) Mutagenicity of vinyl chloride, chloroethylene oxide and chloroacetaldehyde, and chloroethanol. Biochem. Biophys. Res. Commun., 63, 363-370.
11. Loprieno,N., Barale,R., Baroncelli,S., et al. (1977) Induction of gene mutations and gene conversions by vinyl chloride metabolites in yeast. Cancer Res., 37, 253-257.
12. Zajdela,F., Croisy,A., Barbin,A., Malaveille,C. Tomatis,L. and Bartsch,H. (1980) Carcinogenicity of chloroethylene oxide, an ultimate reactive metabolite of vinyl chloride, and bis(chloromethyl)ether after subcutaneous administration and in initiation-promotion experiments in mice. Cancer Res., 40, 352-356.
13. Chiang,S.-Y., Swenberg,J.A., Weisman,W. and Skopek,T.R. (1997) Mutagenicity of vinyl chloride and its reactive metabolites, chloroethylene oxide and chloroacetaldehyde, in a metabolically competent human B-lymphoblastoid line. Carcinogenesis. 18, 31-36.
14. 4-ethenocytosine and 4-amino-5-(imidazol-2-yl). Biochemistry, 32, 12793-12801.
15. Moriya,M., Zhang,W., Johnson,F. and Grollman,A.P. (1994) Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. USA, 91, 11899-11903.
16. Bartsch,J., Barbin,A., Marion,M.-J. and Guichard,Y. (1994) Formation, detection and role in carcinogenesis of ethenobases in DNA. Drug Metab. Rev., 26, 349-371.
17. 4-ethenocytosine, DNA reaction products of vinyl chloride metabolites, during in-vitro DNA synthesis. Nucleic Acids Res., 9, 375-387.
18. 2,3-ethenoguanosine is a highly efficient mutagen in transcription. Carcinogenesis, 8, 745-747.
19. Dosanjh,M., Chenna,E., Kim,E., Fraenkel-Conrat,H., Samson,L. and Singer,B. (1994) All 4 known cyclic adducts formed in DNA by the vinyl chloride metabolite chloroacetaldehyde are released by a human DNA glycosylase. Proc. Natl. Acad. Sci. USA, 91, 1024-1028.
20. 4-ethenocytosine are excised by separate human DNA glycosylases. Carcinogenesis, 17, 155-157.
21. 4-ethenocytosine or 8-oxoguanine. Proc. Natl. Acad. Sci. USA, 94, 12869-12874.
22. Shuker,D., Prevost,V., Friesen,M., Lin,D., Ohshima,H. and Bartsch,H. (1993) Urinary markers for measuring exposure to endogenous and exogenous alkylating agents and precursors. Environ. Health Perspect., 99, 33-37.
23. Shuker,D. and Farmer,P. (1992) Relevance of urinary DNA adducts as markers of carcinogen exposure. Chem. Res. Toxicol., 5, 450-461.
24. Stillwell,W.G., Glogowski,J., Xu,H.X., Wishnok,J.S., Avala,D., Montes,G., Correa, P. and Tannenbaum,S.R. (1991) Urinary excretion of nitrate, N-nitrosoproline, 3-methyladenine, and 7-methylguanine in a Columbian population at high risk for stomach cancer. Cancer Res., 51, 190-194.
25. Stillwell,W.G., Xu,H.X., Adkins,J.A., Wishnok,J.S. and Tannenbaum,S.R. (1989) Analysis of methylated and oxidized purines in urine by capillary gas chromatography-mass spectrometry. Chem. Res. Toxicol., 2, 307-311.
26. Friesen,M.D., Garren,L., Prevost,V. and Shuker,D.E. (1991) Isolation of urinary 3-methyladenine using immunoaffinity columns prior to determination by low-resolution gas chromatography-mass spectrometry. Chem. Res. Toxicol., 4, 102-106.
27. Prevost, V., Shuker,D.E.G., Bartsch,H., Pastorelli,R., Stillwell,W.G., Trudel,L.J. and Tannenbaum,S.R. (1990) The determination of urinary 3-methyladenine by immunoaffinity chromatography-monoclonal antibody-based ELISA: use in human biomonitoring studies. Carcinogenesis, 11, 1747-1751.
28. Walling,C. and Fredricks,P.S. (1962) Positive halogen compounds. IV. Radical reactions of chlorine and t-butyl hypochlorite with some small ring compounds. J. Am. Chem. Soc., 84, 3326-3331.
29. Bennett,R.A., Essigmann,J.M. and Wogan,G.N. (1981) Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats. Cancer Res., 41, 650-654.
30. 32P-postlabeling in the study of human exposure to carcinogens. In Groopman,J.D. and Skipper,P.L. (eds) Molecular Dosimetry and Human Cancer. CRC Press, Boca Raton, FL, pp. 151-170.
31. Topal,M. and Baker,M. (1982) DNA precursor pool: a significant target for B methyl-N-nitrosourea in C3H/10T2 clone 8 cells. Proc. Natl. Acad. Sci. USA, 79, 2211-2215.
32. 6-ethenoadenine in rat urine by immunoaffinity extraction combined with liquid chromatography/electrospray ionization mass spectrometry, Chem. Res. Toxicol, 11, 810-815.
33. 2,3-ethenoguanine in rat tissue DNA. Carcinogenesis, 11, 1287-1292.
34. Swenberg,J.A., Fedtke,N., Ciroussel,F., Barbin,A. and Bartsch,H. (1992) Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver. Carcinogenesis, 13, 727-729.
35. 2-ethenodeoxyguanosine as a potential marker for DNA adduct formation by trans-4-hydroxy-2-nonenal. Cancer Res., 48, 320-323.
36. 4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem. Res. Toxicol., 8, 278-283.